 Neovascularization, Pathologic
"Neovascularization, Pathologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathologic process consisting in proliferation of blood vessels in abnormal tissues or in abnormal positions.
| Descriptor ID |
D009389
|
| MeSH Number(s) |
C23.550.589.500
|
| Concept/Terms |
Neovascularization, Pathologic- Neovascularization, Pathologic
- Pathologic Neovascularization
- Neovascularization, Pathological
- Pathological Neovascularization
- Pathologic Angiogenesis
- Angiogenesis, Pathologic
- Angiogenesis, Pathological
- Pathological Angiogenesis
|
Below are MeSH descriptors whose meaning is more general than "Neovascularization, Pathologic".
Below are MeSH descriptors whose meaning is more specific than "Neovascularization, Pathologic".
This graph shows the total number of publications written about "Neovascularization, Pathologic" by people in this website by year, and whether "Neovascularization, Pathologic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1982 | 0 | 1 | 1 | | 1984 | 1 | 0 | 1 | | 1985 | 1 | 0 | 1 | | 1986 | 1 | 0 | 1 | | 1987 | 1 | 0 | 1 | | 1988 | 0 | 1 | 1 | | 1989 | 0 | 1 | 1 | | 1991 | 1 | 1 | 2 | | 1992 | 1 | 0 | 1 | | 1994 | 1 | 0 | 1 | | 1996 | 9 | 0 | 9 | | 1997 | 1 | 1 | 2 | | 1998 | 4 | 3 | 7 | | 1999 | 4 | 4 | 8 | | 2000 | 5 | 2 | 7 | | 2001 | 7 | 4 | 11 | | 2002 | 7 | 4 | 11 | | 2003 | 5 | 6 | 11 | | 2004 | 11 | 10 | 21 | | 2005 | 4 | 5 | 9 | | 2006 | 5 | 3 | 8 | | 2007 | 5 | 9 | 14 | | 2008 | 8 | 3 | 11 | | 2009 | 8 | 6 | 14 | | 2010 | 5 | 5 | 10 | | 2011 | 4 | 6 | 10 | | 2012 | 13 | 8 | 21 | | 2013 | 8 | 5 | 13 | | 2014 | 5 | 0 | 5 | | 2015 | 5 | 1 | 6 | | 2016 | 2 | 1 | 3 | | 2017 | 2 | 2 | 4 | | 2018 | 0 | 3 | 3 | | 2019 | 4 | 2 | 6 | | 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Neovascularization, Pathologic" by people in Profiles.
-
Jana S, Madhu Krishna B, Singhal J, Horne D, Awasthi S, Salgia R, Singhal SS. SOX9: The master regulator of cell fate in breast cancer. Biochem Pharmacol. 2020 04; 174:113789.
-
Zhang K, Yang L, Wang J, Sun T, Guo Y, Nelson R, Tong TR, Pangeni R, Salgia R, Raz DJ. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer. Cell Commun Signal. 2019 12 16; 17(1):167.
-
Labadie BW, Liu P, Bao R, Crist M, Fernandes R, Ferreira L, Graupner S, Poklepovic AS, Duran I, Maleki Vareki S, Balar AV, Luke JJ. BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma. J Transl Med. 2019 11 25; 17(1):386.
-
Ko SY, Lee W, Kenny HA, Dang LH, Ellis LM, Jonasch E, Lengyel E, Naora H. Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake. Commun Biol. 2019; 2:386.
-
Krishna BM, Jana S, Singhal J, Horne D, Awasthi S, Salgia R, Singhal SS. Notch signaling in breast cancer: From pathway analysis to therapy. Cancer Lett. 2019 10 01; 461:123-131.
-
Karginova O, Weekley CM, Raoul A, Alsayed A, Wu T, Lee SS, He C, Olopade OI. Inhibition of Copper Transport Induces Apoptosis in Triple-Negative Breast Cancer Cells and Suppresses Tumor Angiogenesis. . 2019 05; 18(5):873-885.
-
Stehlik J, Armstrong B, Baran DA, Bridges ND, Chandraker A, Gordon R, De Marco T, Givertz MM, Heroux A, Iklé D, Hunt J, Kfoury AG, Madsen JC, Morrison Y, Feller E, Pinney S, Tripathi S, Heeger PS, Starling RC. Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18. Am J Transplant. 2019 05; 19(5):1518-1528.
-
Innocenti F, Jiang C, Sibley AB, Etheridge AS, Hatch AJ, Denning S, Niedzwiecki D, Shterev ID, Lin J, Furukawa Y, Kubo M, Kindler HL, Auman JT, Venook AP, Hurwitz HI, McLeod HL, Ratain MJ, Gordan R, Nixon AB, Owzar K. Genetic variation determines VEGF-A plasma levels in cancer patients. Sci Rep. 2018 11 05; 8(1):16332.
-
Gudmundsson E, Labby Z, Straus CM, Sensakovic WF, Li F, Rose B, Cunliffe A, Kindler HL, Armato SG. Dynamic contrast-enhanced CT for the assessment of tumour response in malignant pleural mesothelioma: a pilot study. Eur Radiol. 2019 Feb; 29(2):682-688.
-
Li M, Mulkey F, Jiang C, O'Neil BH, Schneider BP, Shen F, Friedman PN, Momozawa Y, Kubo M, Niedzwiecki D, Hochster HS, Lenz HJ, Atkins JN, Rugo HS, Halabi S, Kelly WK, McLeod HL, Innocenti F, Ratain MJ, Venook AP, Owzar K, Kroetz DL. Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clin Cancer Res. 2018 10 01; 24(19):4734-4744.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|